Authors: Seidman, AD Fornier, MN Esteva, FJ Tan, L Kaptain, S Bach, A Panageas, KS Arroyo, C Valero, V Currie, V Gilewski, T Theodoulou, M Moynahan, ME Moasser, M Sklarin, N Dickler, M D'Andrea, G Cristofanilli, M Rivera, E Hortobagyi, GN Norton, L Hudis, CA

Citation: Ad. Seidman et al., Weekly trastuzumab and paclitaxel therapy for metastatic breast cancer with analysis of efficacy by HER2 immunophenotype and gene amplification, J CL ONCOL, 19(10), 2001, pp. 2587-2595

Authors: Van Poznak, C Seidman, AD Reidenberg, MM Moasser, MM Sklarin, N Van Zee, K Borgen, P Gollub, M Bacotti, D Yao, TJ Bloch, R Ligueros, M Sonenberg, M Norton, L Hudis, C

Citation: C. Van Poznak et al., Oral gossypol in the treatment of patients with refractory metastatic breast cancer: A phase I/II clinical trial, BREAST CANC, 66(3), 2001, pp. 239-248

Authors: D'Andrea, G Fennelly, D Norton, L Baselga, J Gilewski, T Hudis, C Moynahan, ME Raptis, G Sklarin, N Surbone, A Theodoulou, M Templeton, MA Yao, TJ Seidman, AD

Citation: G. D'Andrea et al., Phase I study of escalating doses of edatrexate in combination with paclitaxel in patients with metastatic breast cancer, CLIN CANC R, 5(2), 1999, pp. 275-279

Authors: Hudis, C Fornier, M Riccio, L Lebwohl, D Crown, J Gilewski, T Surbone, A Currie, V Seidman, A Reichman, B Moynahan, M Raptis, G Sklarin, N Theodoulou, M Weiselberg, L Salvaggio, R Panageas, KS Yao, TJ Norton, L

Citation: C. Hudis et al., 5-year results of dose-intensive sequential adjuvant chemotherapy for women with high-risk node-positive breast cancer: A phase II study, J CL ONCOL, 17(4), 1999, pp. 1118-1126

Authors: Hudis, C Seidman, A Baselga, J Raptis, G Lebwohl, D Gilewski, T Moynahan, M Sklarin, N Fennelly, D Crown, JPA Surbone, A Uhlenhopp, M Riedel, E Yao, TJ Norton, L

Citation: C. Hudis et al., Sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide for resectable high-risk breast cancer: Feasibility and efficacy, J CL ONCOL, 17(1), 1999, pp. 93-100